1248.7.01045 Boehringer Ingelheim Investigational Site

Cincinnati, Ohio

0 studies enrolling now · 1 studies all time

What they study most

Asthma

Studies at this site

• Study on BI 54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Medium Dose Inhaled Corticosteroid (ICS). — Stopped early